PCM
XGN icon

Perkins Capital Management’s Exagen XGN Stock Holding History

Perkins Capital Management’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$264K Sell
56,796
-15,000
-21% -$56.5K 0.2% 69
2026
Q1 		$215K Buy
71,796
+53,221
+287% +$206K 0.2% 73
2025
Q4 		$113K Sell
18,575
-1,500
-7% -$13.7K 0.09% 83
2025
Q3 		$221K Sell
20,075
-211,783
-91% -$1.88M 0.19% 71
2025
Q2 		$1.62M Sell
231,858
-191,113
-45% -$1.16M 1.63% 19
2025
Q1 		$1.52M Sell
422,971
-750
-0.2% -$2.83K 1.6% 18
2024
Q4 		$1.74M Sell
423,721
-35,150
-8% -$127K 1.54% 20
2024
Q3 		$1.42M Sell
458,871
-34,450
-7% -$89.3K 1.33% 21
2024
Q2 		$898K Sell
493,321
-250
-0.1% -$423 0.85% 37
2024
Q1 		$785K Sell
493,571
-15,334
-3% -$29.8K 0.65% 49
2023
Q4 		$1.01M Buy
508,905
+245,000
+93% +$424K 0.87% 40
2023
Q3 		$639K Hold
263,905
– – 0.63% 46
2023
Q2 		$765K Buy
263,905
+4,000
+2% +$11.4K 0.67% 46
2023
Q1 		$632K Buy
259,905
+7,500
+3% +$19.4K 0.6% 52
2022
Q4 		$606K Sell
252,405
-5,050
-2% -$13K 0.64% 44
2022
Q3 		$698K Buy
257,455
+20,480
+9% +$114K 0.78% 41
2022
Q2 		$1.36M Buy
236,975
+36,000
+18% +$210K 1.41% 25
2022
Q1 		$1.61M Buy
200,975
+1,500
+0.8% +$12.9K 1.32% 31
2021
Q4 		$2.32M Sell
199,475
-6,755
-3% -$79.1K 1.57% 22
2021
Q3 		$2.81M Buy
206,230
+5,750
+3% +$76.4K 1.74% 18
2021
Q2 		$3M Sell
200,480
-3,050
-1% -$46.8K 1.71% 20
2021
Q1 		$3.56M Buy
203,530
+71,175
+54% +$1.27M 2.06% 13
2020
Q4 		$1.75M Buy
132,355
+12,000
+10% +$169K 1.14% 32
2020
Q3 		$1.3M Buy
+120,355
New +$1.55M 1.2% 30
2020
Q1 		$1.33M Sell
83,650
-2,200
-3% -$43.7K 1.61% 21
2019
Q4 		$2.18M Sell
85,850
-1,600
-2% -$28.5K 1.96% 13
2019
Q3 		$1.35M Buy
+87,450
New +$1.41M 1.17% 31

Other funds holding XGN

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Perkins Capital Management's XGN Position: Q2 2026 in Review

Perkins Capital Management reduced its Exagen (XGN) stake by 21% in Q2 2026, selling an estimated $56.5K and leaving 56,796 shares worth $264K. The position accounts for 0.2% of the portfolio, ranked #69.

Perkins Capital Management first reported a position in XGN in Q3 2019 and has held it in 27 quarters since. The position peaked at $3.56M in Q1 2021. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Perkins Capital Management held 56,796 shares of Exagen worth $264K as of Q2 2026.
  • Perkins Capital Management sold 15,000 Exagen shares in Q2 2026, an estimated $56.5K.
  • Exagen made up 0.2% of Perkins Capital Management's portfolio in Q2 2026, its #69 holding.
  • Perkins Capital Management first reported a position in Exagen in Q3 2019 and has held it in 27 quarters since.
  • Perkins Capital Management's Exagen position peaked at $3.56M in Q1 2021.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Perkins Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.